Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program aimed at streamlining access to weight loss drugs, with ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Amazon is rolling out a new GLP‑1 program aimed at simplifying access to popular weight-loss drugs, from doctor visits to prescription delivery. The company announced on April 21 that Amazon One ...

Amazon.com AMZN0.56%increase; green up pointing triangle is launching a program that provides access to GLP-1 treatments through its One Medical primary care arm. The company said Tuesday the new ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...

Amazon has launched a new weight management program through Amazon One Medical that integrates primary care, pharmacy services and virtual care to support patients using GLP-1 medications. The program ...

St. Mary’s Health Care System announced recently that it is offering a program aimed at those dealing with obesity and weight loss issues. The Intensive Behavioral Therapy is open to people with ...

A molecule that is found in python blood could be the key to creating new weight-loss drugs. Trump’s DoorDash stunt accidentally highlights his biggest political problem What's happening in the Strait ...

Burmese pythons have pretty irregular eating habits. One of these giant reptiles can swallow an entire antelope whole and then go up to a year and a half without additional meals. Now, scientists have ...

Researchers report a python metabolite that suppresses appetite in mice, highlighting a potential alternative to current weight-loss drugs. The study, set against widespread use of GLP-1 drugs such as ...